1 recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Recruiting 1 |
Follow STX-478: new trials by email Literature Review of STX-478 trials Research Report on STX-478
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA) LY4064809, Placebo, Ribociclib - Breast Neoplasms, Neoplasm Metastasis | Phase 3 | Recruiting | Eli Lilly and Company | 800 | 2025-12-22 | 2026-11-04 |
Breast Neoplasms (1) · Neoplasm Metastasis (1)
Argentina (1) · Australia (1) · Belgium (1) · Brazil (1) · Canada (1) · China (1) · France (1) · Germany (1) · Greece (1) · Ireland (1) · Italy (1) · Japan (1) · Singapore (1) · South Korea (1) · Spain (1)
2025 (1)